Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
17OHP for Preterm Birth in Twin and Triplet Pregnancies
NCT00163020Phase 3Completed
- Sponsor
- Obstetrix Medical Group
- Start
- Nov 2004
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hydroxyprogesterone caproate in preterm birth (2 arms), sponsored by Obstetrix Medical Group. Primary endpoints: Newborn Respiratory Distress Syndrome, Use of Oxygen Therapy at 28 Days of Newborn Life and 8 more. Started Nov 2004; status: completed.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT00163020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163020.